He Xun

This profile gathers the share dealings of He Xun in China Biotech Services Holdings Ltd. Between 11 September 2018 and 2 September 2024, the trades on record add up to 6 filings.

Market trades split into 2 purchases and 4 sales. The amount is not disclosed for 6 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2024: no purchases and 1 sale on the market.

The latest filing, published on 5 September 2024, reports an open-market sale in China Biotech Services Holdings Ltd. The last insider purchase was made public on 4 September 2020, 2,242 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.